Specialty Pharmacy fees

[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][info_box title=”” image=”” animate=””]How are other companies treating Specialty Pharmacies Fees (including dispensing fees, prior authorization support services, data fees and shipping fees)? As a GTN deduction or fee for service expense item?[/info_box] [/fusion_builder_column][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][divider height=”30″ style=”default” line=”default” themecolor=”1″] Share Response A We treat it as both and it is determined based on what is driving the […]

December 17, 2014 | Jennifer Guinan

Coverage Gap Pipeline Reserve

October 30, 2014 | Jennifer Guinan

CA Managed Medicaid Share:

CA Managed Medicaid Share (test ajay 2): Notes from a conversation with California Dept. of Health Care Services (Medi-Cal), Robert Shun, the Drug Rebate Branch Chief at California Medicaid; Robert’s understanding that approximately 90% of the pharmacy claims have been processed and manufacturers have been invoiced for claims all the way back to 2010 in the current invoice cycle. Robert stated that Physician administered claims (PADs) processing is only about 40% complete. PADs are typically injected drugs administered in a physician’s office and billed with j-codes. PAD claims were held up by a system implementation. This back-log won’t be cleared […]

October 30, 2014 | Jennifer Guinan

‘Colleague Connect’ Session Summary

Branded Pharma Fee ‘Colleague Connect’ Session Summary [fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][info_box title=”” image=”” animate=””]Revenue Analytics Collaborative Members, Thank you for your participation and encouragement. The Revenue Analytics Collaborative is growing rapidly! This increases the power and value of sharing our collective knowledge! daVIZta hosts informal ‘Colleague Connect’ sessions and one of our most recent sessions was for Branded Pharma Fee. Below are some brief summary discussion points. These are not the opinion or recommendations of daVIZta, only an anonymous sharing […]

1 2 Next »